Objective: Efficient diagnostic pathways in advanced non-small cell lung cancer (NSCLC) are crucial for timely treatment initiation and improved outcomes. This study evaluated the impact of diagnostic ...
Credit: Getty Images When is it too late for a patient to file a medical malpractice claim? Sometimes it's unclear exactly when the statute of limitations countdown begins. When is it too late for a ...
UPPER SAUCON TWP., Pa.- Olympus Corporation is expanding its global recall for a certain type of needle, following reports of patient injuries and one death. The recall, first announced last August, ...
California's Leadoptik, developer of a miniaturized imaging platform for minimally invasive surgical procedures, has announced FDA 510(k) clearance for its Last Inch Assessment (LIA) technology, an ...
As lung cancer remains one of the leading causes of cancer-related deaths globally, healthcare providers and industry leaders are turning to advanced, minimally invasive diagnostics to improve patient ...
Lung cancer mortality has declined in recent years after decades of limited progress; however, it remains the leading cause of cancer-related deaths. This encouraging trend is partly attributed to ...
A year ago, McLaren Greater Lansing invested $700,000 to purchase an Ion Robotic Bronchoscopy, a platform for minimally invasive peripheral lung biopsy. “Ion provides us with the ability to biopsy any ...
Background Bronchoscopic limitations in reaching peripheral pulmonary lesions (PPLs) can compromise biopsy sensitivity, especially for small PPLs. Therefore, we developed the balloon dilatation for ...
Olympus has issued a recall of ViziShot 2 FLEX EBUS -TBNA needles manufactured before May 12, 2025. The company has received several reports of device components detaching during procedures, leading ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results